Apoptosis in the ischemic reperfused myocardium

Perfusion

Volumn 16, Issue 6, 2001, Pages 491-502

  Holleyman, C R ^a   Larson, D F ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; REACTIVE OXYGEN METABOLITE; ANTIOXIDANT;

ANIMAL CELL; APOPTOSIS; ARTICLE; BLOOD FLOW; CARDIOPULMONARY BYPASS; CELL DEATH; CELL STIMULATION; CELL SURVIVAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; ENDOTHELIUM CELL; ENERGY METABOLISM; ENZYME SUBSTRATE; GENE CONTROL; HEART MUSCLE CELL; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HEART MUSCLE REPERFUSION; HEART PERFUSION; INFLAMMATION; MACROPHAGE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PUMP; RAT; REPERFUSION INJURY; SECOND MESSENGER; SIGNAL TRANSDUCTION; STRESS; TISSUE METABOLISM; TISSUE PRESERVATION; DRUG EFFECT; HUMAN; PATHOLOGY; PHYSIOLOGY; REVIEW;

ANTIOXIDANTS; APOPTOSIS; CYTOKINES; HUMAN; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION; MYOCARDIAL REPERFUSION INJURY;

EID: 0035181640     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1177/026765910101600609     Document Type: Article

References (85)

1. Part VI: Coronary heart disease
2. Coronary circulation
3. Mitochondrial structure and function in acute myocardial ischemic injury
4. Effect of a transient period of ischemia on myocardial cells. I. Effects on cell volume regulation
5. Reperfusion injury induces apoptosis in rabbit cardiomyocytes
6. Necrosis and apoptosis: Distinct modes of cell death with fundamentally different significance
7. Programmed cell death in the progression of heart failure
8. Apoptosis in the heart
9. Death by design. Programmed cell death in cardiovascular biology and disease
10. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3
11. Apoptosis: An overview of the process and its relevance in disease
12. Control of apoptosis by proteases
13. Death and dying in the immune system
14. Bcl-2 family proteins: Strategies for overcoming chemoresistance in cancer
15. Programmed cell death and expression of the protooncogene bcl-2 in myocytes during postnatal maturation of the heart
16. Tumor necrosis factor in myocardial hypertrophy and ischaemia - An anti-apoptotic perspective
17. A novel domain within the 55 kd TNF receptor signals cell death
18. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways
19. Caspases and caspase inhibitors
20. Reperfusion injury: Laboratory artifact or clinical dilemma?
21. A chronic mouse model of myocardial ischemia-reperfusion: Essential in cytokine studies
22. Ceramide is involved in triggering of cardiomyocyte apoptosis induced by ischemia and reperfusion
23. Tumor necrosis factor-alpha is released from the isolated heart undergoing ischemia and reperfusion
24. Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death
25. Oxidative stress during myocardial ischaemia and heart failure
26. Signaling pathways in reactive oxygen species-induced cardiomyocyte apoptosis
27. The role of nitric oxide and cell adhesion molecules on the microcirculation in ischaemia-reperfusion
28. The 1996 Albert Lasker Medical Research Awards. The discovery of endothelium-derived relaxing factor and its importance in the identification of nitric oxide
29. Inhibition of endogenous nitric oxide synthase potentiates ischemia-reperfusion-induced myocardial apoptosis via a caspase-3 dependent pathway
30. Demonstration of free radical generation in 'stunned' myocardium of intact dogs with the use of the spin trap alpha-phenyl N-tert-butyl nitrone
31. Reduction of the extent os ischemic myocardial injury by neutrophil depletion in the dog
32. Modulation of cytokine-induced cardiac myocyte apoptosis by nitric oxide, Bak, and Bcl-x
33. Suppression of apoptosis by nitric oxide via inhibition of interleukin-1beta-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases
34. The L-arginine-nitric oxide pathway
35. Inflammatory response to cardiopulmonary bypass using roller or centrifugal pumps
36. Regulation of lipopolysaccharide-induced NO synthase expression in the major organs in a mouse model. The roles of endogenous interferon-gamma, tumor necrosis factor-alpha and interleukin-10
37. Nitric oxide contributes to the progression of myocardial damage in experimental autoimmune myocarditis in rats
38. Cytokine-mediated apoptosis in cardiac myocytes: The role of inducible nitric oxide synthase induction and peroxynitrite generation
39. Mitochondrial nitric-oxide synthase stimulation causes cytochrome c release from isolated mitochondria. Evidence for intramitochondrial peroxynitrite formation
40. Free radicals and apoptosis of the endothelial cells
41. Tumor necrosis factor in the heart
42. MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1
43. Increased levels of myocardial IkappaB-alpha protein promote tolerance to endotoxin
44. Signal transduction through lipid second messengers
45. Signal transduction of stress via ceramide
46. prICE: A downstream target for ceramide-induced apoptosis and for the inhibitory action of Bcl-2
47. Rapid activation of neutral sphingomyelinase by hypoxia-reoxygenation of cardiac myocytes
48. Tissue-specific pattern of stress kinase activation in ischemic/reperfused heart and kidney
49. Activation of mitogen-activated protein kinases in human during cardiopulmonary bypass
50. T cells expressing the gamma delta T cell receptor induce apoptosis in cardiac myocytes
51. Granule-mediated killing: Pathways for granzyme B-initiated apoptosis
52. Caspase inhibition reduces myocyte cell death induced by myocardial ischemia and reperfusion in vivo
53. Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor
54. Inhibition of apoptosis after ischemia-reperfusion in rat myocardium by cycloheximide
55. Overexpression of bcl-2 gene improves the myocardial tolerances to ischemia-reperfusion by preventing DNA fragmentation
56. Bcl-2 functions in an antioxidant pathway to prevent apoptosis
57. Altered levels of mRNA of apoptosis-mediating genes after mid-term mechanical ventricular support in dilative cardiomyopathy - First results of the Halle Assist Induced Recovery Study (HAIR)
58. Delayed myocardial preconditioning by alpha1-adrenoceptors involves inhibition of apoptosis
59. Preconditioning decreases Bax expression, PMN accumulation and apoptosis in reperfused rat heart
60. Adenosine reduces cardiac TNF-alpha production and human myocardial injury following ischemia-reperfusion
61. Inosine inhibits inflammatory cytokine production by a posttranscriptional mechanism and protects against endotoxin-induced shock
62. Inosine infusion in dogs with acute ischaemic left ventricular failure: Favourable effects on myocardial performance and metabolism
63. The rationale for the current boom in anti-TNF alpha treatment. Is there an effective means to define therapeutic targets for drugs that provide all the benefits of anti-TNF alpha and minimise hazards?
64. Clinical implications of tumour necrosis factor alpha antagonism in patients with congestive heart failure
65. Interleukin 6 induction in the canine myocardium after cardiopulmonary bypass
66. Biocompatibility of heparin-coated extracorporeal bypass circuits: New heparin bonded bioline system
67. Humoral immune response during coronary artery bypass grafting: A comparison of limited approach, 'Off-Pump' technique, and conventional cardiopulmonary bypass
68. Circulating soluble gp130, soluble IL-6R, and IL-6 in patients undergoing cardiac surgery, with or without extracorporeal circulation
69. Cardiotrophin-1 protects the human myocardium from ischemic injury: Comparison with the first and second window of protection by ischemic preconditioning
70. Cardiotrophin-1: A novel cytokine and its effects in the heart and other tissues
71. Cardiotrophin 1 (CT-1) inhibition of cardiac myocyte apoptosis via a mitogen-activated protein kinase-dependent pathway. Divergence from downstream CT-1 signals for myocardial cell hypertrophy
72. Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress
73. Reactive oxygen species and apoptosis
74. Neurohormonal activation, oxygen free radicals, and apoptosis in the pathogenesis of congestive heart failure
75. Carvedilol, a new beta adrenoreceptor blocker and free radical scavenger, attenuates myocardial ischemia-reperfusion injury in hypercholesterolemic rabbits
76. Carvedilol prevents low-density lipoprotein (LDL)-enhanced monocyte adhesion to endothelial cells by inhibition of LDL oxidation
77. Chinonin, a novel drug against cardiomyocyte apoptosis induced by hypoxia and reoxygenation
78. Metalloporphyrin class of therapeutic catalytic antioxidants
79. Reactive oxygen species regulate activation-induced T cell apoptosis
80. A novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase
81. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages
82. Annexin V-affinity assay: A review on an apoptosis detection system based on phosphatidylserine exposure
83. Visualisation of cell death in vivo in patients with acute myocardial infarction
84. In vivo detection and imaging of phosphatidylserine expression during programmed cell death
85. Cardiomyocyte apoptosis induced by ischaemia and reperfusion in murine hearts: Early detection with labelled annexin-V